Broward Health Coral Springs offers elite cardiac services

For many years Broward Health Coral Springs (BHCS) provided cardiac care services to the community, but one key component was missing—a cardiac catheterization lab for emergency catheterizations. Subsequently, patients were transported to other facilities, but that’s no longer the case.

Last June, a new state-of-the-art cath lab became operational at BHCS. “We now have the ability to care for specifi c patients with ST Elevation Myocardial Infarctions (STEMI),” said Mohamed Osman, M.D., director of the Cardiac Catheterization Laboratory and specialist in Interventional Cardiology at BHCS. “This is a unique opportunity to provide an even higher level of care through angioplasty procedures.”

Designated as a Level 1 Heart Program by the Agency for Healthcare Administration, the new cath lab was termed a “milestone” by hospital CEO Jared Smith, one that “increases our ability to provide a high level of care and uphold our recognition (per Our City Magazine) as the area’s best hospital and Emergency Department.”

Gary Lai, D.O., and chief of Emergency Medicine says the addition of the STEMI heart program makes it possible for EMS to pre-alert the ER and send electrocardiograms prior to a patient’s arrival. “We can prepare immediately to stabilize, medicate, and expedite patients to the in-house cath lab,” he said. “This saves lives and maximizes outcomes.”

The new catheterization lab allows BHCS specialists to perform invasive cardiac procedures and utilize advanced imaging for diagnoses by using contrast dye to determine the severity of the arterial blockage. Once identified, a balloon angioplasty is performed, or a stent is inserted to clear the artery and save as much of the heart muscle as possible. Pacemakers and defibrillator implant procedures are also performed.

Generally speaking, the last 20 years has seen a rapid transformation of new techniques focusing on minimally invasive procedures, rapid care, and shorter hospital stays, according to Dr. Osman. “Although open heart surgery is certainly an option, the major shift has been toward less invasive, less traumatic procedures that obtain excellent results.” People with severe heart valve problems always required open heart surgery. A significant number are now treated with stents to reduce the risk of a major heart event.

Surgical progress in cardiology can be defi ned by an alphabet soup of acronyms: SAVR (Surgical Aortic Valve Replacement); CABG (Coronary Artery Bypass Graft); BAG (Bilateral Arterial Grafting); PCI (Percutaneous Coronary Intervention); TAVR (Transcatheter Aortic Valve Replacement); EVAR (Endovascular Abdominal Aneurysm Repair): and ICD (Implantable Cardioverter Defi brillator). The term Electrophysiology refers to leadless pacemakers and remote monitoring devices. “Because of these techniques, patients spend less time in the hospital, recover faster, and there’s less trauma to the body,” said Dr. Osman. “An aortic valve replacement once required open heart surgery, but now the TAVR procedure accomplishes the same goal by inserting a transcatheter through a small incision in the groin.”

Surgical complications 

Any medical procedure has the potential for complications such as excessive bleeding, stroke, and even death, but the key is how often complications occur as a result of surgery. “Both minor and major complications are possible, but keep in mind that no patient is the same,” said Dr. Osman. “If a younger patient requires open heart surgery the only problem is the heart and nothing else, so the focus is isolated, but older patients—especially those with underlying conditions such as diabetes, kidney problems, or a previous stroke, are in a high- risk category for complications,” the specialist said.

To show that one size doesn’t fit all, Dr. Osman uses the example of two patients with the same high percentage of blockage that would be treated differently. “The one who is asymptomatic can be treated with medications and dietary changes, while the other who has difficulty breathing and may have underlying medical conditions is a prime candidate for a stent.” He reminds us that everyone is different, and each patient requires a different mode of treatment depending on general health and underlying conditions. “The key is a full evaluation to create a treatment plan with the best benefit.”

Dr. Osman refers to the doctor-patient relationship as “the art of medicine.” The unique relationship includes listening, evaluating, diagnosing, and treating. “At the end of the day when pieces of the ‘puzzle’ come together it’s the collaboration between the surgeon and interventional cardiologist that makes it happen,” he said. He recently saw a patient with a 90-percent blockage of the artery. CABG open heart surgery was performed, and the person is expected to make a full recovery. Choosing the right therapy is the goal.

The COVID consequence

When COVID’s first wave peaked in March 2020, it impacted cardiology services.

With a focus on caring for acute COVID patients, the shift was away from elective cardiac procedures. “Many patients feared coming to the hospital out of fear of COVID and that posed a huge problem,” said Dr. Osman. “In cardiology, time is a big factor and the longer treatment is delayed the worse a condition can become.” He cited a patient who suffered a heart attack yet remained at home for two days. They were able to save his life, but the heart muscle was significantly damaged and he’s now living with a very weak heart muscle. “Things like this are still happening but not to such a high degree. Remember that the margin of error is much less with age,” he said.

The medical facility keeps a log on how long it takes after arrival in the ER to when a clogged artery is opened in the cath lab. According to Dr. Osman the best time to date has been 23 minutes.

2021-The year of the vaccine

We’ve closed the book on an unexpected 2020, where so much of our lives were dominated by the pandemic. COVID-19 will still be with us this year, but we hope our lives will slowly recover in 2021 as vaccines are made available for everyone.

Creating a new vaccine is time-consuming. Unlike the flu vaccine for the H1N1 pandemic in 2009, there is no existing vaccine for coronaviruses to build upon. According to the CDC, COVID-19 vaccines must be developed and tested to ensure they work and are safe. Michal Linial, a professor of biological chemistry at the Hebrew University of Jerusalem said “Classical vaccines were designed to take 10 years to develop.” So a new vaccine process is now being used for the early COVID-19 vaccines.

As of December 15th, three vaccines have been submitted for FDA approval. There are two mRNA (messenger RNA) vaccines by Pfi zer and Moderna, and one DNA vaccine by Oxford-AstraZeneca. Both of these methods are relatively new, and until COVID-19, no DNA or mRNA vaccines had been approved in the US for human use.

The basic concept these vaccines use is to trick your body into producing proteins that appear to be similar to COVID-19 fragments, which will elicit an immune response from your body’s defense system. This response will protect you from infection from the live virus. This is a new process, compared to vaccines based on live or dead pathogen proteins. The new DNA and mRNA vaccines are non-infectious and can be produced faster and economically.

Both mRNA and DNA vaccines use your body to produce the proteins, using the instructions stored in either mRNA or DNA format. DNA instructions are processed inside your body’s cells to produce the proteins designed to emulate fragments from the virus; whereas mRNA is translated into the protein outside of the cell in your body’s intracellular fluid.

Since mRNA does not enter your cell, the chance of your genome being affected is averted. But mRNA is fragile, thus the cold storage requirements for these vaccines: -70 degrees Celsius for Pfi zer, and -20 degrees Celsius for Moderna. The advantage of the DNA vaccine like the Oxford-AstraZeneca version is to reach areas where cold storage is not common.

The minor and moderate side effects reported of these early vaccines are sore arm at the injection site, fever, fatigue, headache, joint pains, and muscle aches. These effects are due to your body ramping up for a virus infection, but because the vaccine is non-infectious, you will not get a case of COVID-19, just the symptoms from your body’s response.

According to Moderna, no one receiving the vaccine in their trials developed a severe case of COVID-19. The reported efficacy rate for these vaccines are in the 90-95% range, which is much higher than your typical flu vaccine.

While the creation and approval of these first sets of vaccines have been completed, the logistics of getting them delivered across the country has just begun. Operation Warp Speed (OWS), is a partnership between the Department of Health and Human Services (HHS), including the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Biomedical Advanced Research and Development Authority (BARDA), and the Department of Defense (DoD).

OWS aims to accelerate the development, manufacture, and distribution of COVID-19 vaccines. Their stated distribution objective “is for everyone to be able to easily get a COVID-19 vaccine as soon as large quantities are available. Several thousand vaccination providers will be available, including doctors’ offices, retail pharmacies, hospitals, and federally qualified health centers.”

OWS has provided a playbook to state and local jurisdictions on the distribution of the vaccines. In Florida, the Division of Emergency Management (FDEM), an agency headed by Director Jared Moskowitz, a Parkland local, is responsible for the distribution of vaccines across the state. “We went out and bought dry ice machines,” said Director Moskowitz. “We got the ultra-cold freezers that we need. We feel that we’re in a good position.

Gov. Ron DeSantis said the state has been planning since early summer on how best to distribute the vaccines, with initial distribution planned at five Florida hospitals (including Memorial Healthcare System in Broward), and eventually expanding to look like state testing sites. “It may even be the same sites we have now,” Moskowitz said. “Giving out the vaccine in a mass distribution — call it spring, late spring, early summer.”

So we say good riddance to 2020. There is much hope life will start returning to normal as more folks are vaccinated in 2021. As of Dec 15th, 2020, a new hope is slowly arriving in the form of vaccines, and state officials work through the prioritization process. The logistics of successfully implementing a smooth mass vaccination is immense, and we all need to follow the recommendations so we can get back to the OLD normal as quickly as possible.

Welcome to 2021, the year of the vaccine.